Current Environment: Production

English | Education

Medical School

Albert Einstein College of Medicine

Bronx, NY

Residency

Floating Hospital for Children, Tufts Medical Center

Boston, MA

Fellowship

Boston Children's Hospital

Boston, MA

English | Publications

  1. Smith-Lemli-Opitz Syndrome: Clinical, Biochemical, and Genetic Insights With Emerging Treatment Opportunities. Genet Med. 2025 Apr 29; 101450. View Smith-Lemli-Opitz Syndrome: Clinical, Biochemical, and Genetic Insights With Emerging Treatment Opportunities. Abstract

  2. Genotype-Phenotype Landscape of NALCN and UNC80-Related Disorders. Neurology. 2025 Apr 08; 104(7):e213429. View Genotype-Phenotype Landscape of NALCN and UNC80-Related Disorders. Abstract

  3. A 4-Month-Old With Jaundice, Lethargy, and Emesis. Pediatrics. 2024 Oct 01; 154(4). View A 4-Month-Old With Jaundice, Lethargy, and Emesis. Abstract

  4. Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. Nat Commun. 2024 Aug 22; 15(1):7239. View Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. Abstract

  5. Prenatal molecular diagnosis of pyruvate dehydrogenase complex deficiency enables rapid initiation of ketogenic diet. Am J Med Genet A. 2024 Dec; 194(12):e63825. View Prenatal molecular diagnosis of pyruvate dehydrogenase complex deficiency enables rapid initiation of ketogenic diet. Abstract

  6. PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response. Am J Hum Genet. 2024 07 11; 111(7):1352-1369. View PSMD11 loss-of-function variants correlate with a neurobehavioral phenotype, obesity, and increased interferon response. Abstract

  7. Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program. Mol Genet Metab. 2024 May; 142(1):108350. View Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program. Abstract

  8. Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. medRxiv. 2024 Jan 31. View Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy. Abstract

  9. Reinstitution of pegvaliase therapy during lactation. Mol Genet Metab Rep. 2022 Dec; 33:100938. View Reinstitution of pegvaliase therapy during lactation. Abstract

  10. Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes. Pediatr Res. 2023 01; 93(1):110-117. View Rare diseases, common barriers: disparities in pediatric clinical genetics outcomes. Abstract

  11. A novel nonsense variant in the NFE2L1 transcription factor in a patient with developmental delay, hypotonia, genital anomalies, and failure to thrive. Hum Mutat. 2022 04; 43(4):471-476. View A novel nonsense variant in the NFE2L1 transcription factor in a patient with developmental delay, hypotonia, genital anomalies, and failure to thrive. Abstract

  12. Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center. Child Abuse Negl. 2022 03; 125:105480. View Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center. Abstract

  13. Emergency Laboratory Evaluations for Patients With Inborn Errors of Metabolism. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1154-e1159. View Emergency Laboratory Evaluations for Patients With Inborn Errors of Metabolism. Abstract

  14. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Hum Genet. 2022 Jan; 141(1):65-80. View MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects. Abstract

  15. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021 07; 53(7):1006-1021. View Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Abstract

  16. Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders. Am J Hum Genet. 2021 08 05; 108(8):1450-1465. View Unique variants in CLCN3, encoding an endosomal anion/proton exchanger, underlie a spectrum of neurodevelopmental disorders. Abstract

  17. Use of skimmed breast milk for an infant with a long-chain fatty acid oxidation disorder: A novel therapeutic intervention. JIMD Rep. 2020 Sep; 55(1):44-50. View Use of skimmed breast milk for an infant with a long-chain fatty acid oxidation disorder: A novel therapeutic intervention. Abstract

  18. First 1.5 years of pegvaliase clinic: Experiences and outcomes. Mol Genet Metab Rep. 2020 Sep; 24:100603. View First 1.5 years of pegvaliase clinic: Experiences and outcomes. Abstract

  19. A phenotypically severe, biochemically "silent" case of HIBCH deficiency in a newborn diagnosed by rapid whole exome sequencing and enzymatic testing. Am J Med Genet A. 2020 04; 182(4):780-784. View A phenotypically severe, biochemically "silent" case of HIBCH deficiency in a newborn diagnosed by rapid whole exome sequencing and enzymatic testing. Abstract

  20. Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report. Mol Genet Metab Rep. 2020 Mar; 22:100555. View Discontinuation of Pegvaliase therapy during maternal PKU pregnancy and postnatal breastfeeding: A case report. Abstract

  21. Quality improvement: The tools we need to improve care for patients with inborn errors of metabolism. Mol Genet Metab. 2020 01; 129(1):1-2. View Quality improvement: The tools we need to improve care for patients with inborn errors of metabolism. Abstract

  22. Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients. Mol Genet Metab Rep. 2019 Dec; 21:100530. View Early initiation of enzyme replacement therapy in classical Fabry disease normalizes biomarkers in clinically asymptomatic pediatric patients. Abstract

  23. Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Cold Spring Harb Mol Case Stud. 2018 08; 4(4). View Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Abstract

  24. Megaloblastic Anemia Progressing to Severe Thrombotic Microangiopathy in Patients with Disordered Vitamin B12 Metabolism: Case Reports and Literature Review. J Pediatr. 2018 11; 202:315-319.e2. View Megaloblastic Anemia Progressing to Severe Thrombotic Microangiopathy in Patients with Disordered Vitamin B12 Metabolism: Case Reports and Literature Review. Abstract

  25. Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox. J Pediatr. 2018 07; 198:313-316. View Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox. Abstract

  26. Cerebellar cognitive affective syndrome: insights from Joubert syndrome. Cerebellum Ataxias. 2018; 5:5. View Cerebellar cognitive affective syndrome: insights from Joubert syndrome. Abstract

English | Education

Undergraduate School

Harvard College

2005, Cambridge, MA

Medical School

University of Michigan Medical School

2009, Ann Arbor, MI

Internship

Johns Hopkins Children's Center

2010, Baltimore, MD

Residency

Johns Hopkins Children's Center

2012, Baltimore, MD

Fellowship

Academic Pediatric Division of General Pediatrics and Pediatric Health Services Research

Boston Children's Hospital

2014, Boston, MA

Graduate School

Harvard T.H. Chan School of Public Health

2014, Boston, MA

English | Publications

English | Education

Medical School

Harvard Medical School

1994, Boston, MA

Internship

Beth Israel Deaconess Medical Center

1995, Boston, MA

Residency

Orthopedic Surgery

Harvard Combined Orthopedic Residency Program

1999, Boston, MA

Fellowship

Boston Children's Hospital

2000, Boston, MA

Fellowship

Texas Scottish Rite Hospital

2000, Dallas, TX

English | Publications

English | Education

Undergraduate School

Case Western Reserve University

1967, Cleveland, OH

Medical School

Tufts University School of Medicine

1967, Boston, MA

Internship

Boston Floating Hospital/New England Medical Center

1974, Boston, MA

English | Education

Medical School

Pritzker School of Medicine, University of Chicago

1989, Chicago, IL

Internship

University of Chicago

1990, Chicago, IL

Residency

Massachusetts General Hospital

1992, Boston, MA

Fellowship

Boston Children's Hospital

1993, Boston, MA

Fellowship

Massachusetts General Hospital

1993, Boston, MA

English | Publications

English | Education

Medical School

Brown University Program in Medicine

1987, Providence, RI

Internship

Rhode Island Hospital

1988, Providence, RI

Residency

Chief Resident

Rhode Island Hospital

1990, Providence, RI

Fellowship

Pediatric Critical Care

Yale-New Haven Hospital

1994, New Haven, CT

English | Publications

English | Education

Undergraduate School

Dartmouth College

1989, Hanover, NH

Medical School

Duke University School of Medicine

1993, Durham, NC

Internship

Beth Israel Deaconess Medical Center

1994, Boston, MA

Residency

Harvard Combined Orthopaedic Surgery Residency Program

1998, Boston, MA

Fellowship

Pediatric Orthopedic Surgery

Boston Children's Hospital

1999, Boston, MA

Fellowship

Sports Medicine and Arthroscopic Surgery

Steadman Hawkins Clinic

2000, Vail, CO

Graduate School

Harvard School of Public Health

2000, Boston, MA

Graduate School

Harvard Business School

2018, Boston, MA

English | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services